Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles F Burant

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Diabetes Care|July 25, 2013
Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetesCharles F Burant
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 20, 2003
DGAT: novel therapeutic target for obesity and type 2 diabetes mellitusAngela Subauste, Charles F Burant
Nature Medicine|May 7, 2011
PPAR-γ action: it's all in your headMartin G Myers, Charles F Burant
Trends in Endocrinology and Metabolism: TEM|February 21, 2002
Connecting islet development and developing useful isletsCharles F Burant, Diane M Simeone
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2005
Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporterOrmond A MacDougald, Charles F Burant
Cell Metabolism|September 5, 2007
The rapidly expanding family of adipokinesOrmond A MacDougald, Charles F Burant
Nature Cell Biology|June 2, 2005
Fickle factor foils fat fateOrmond A MacDougald, Charles F Burant
American Journal of Physiology. Endocrinology and Metabolism|March 22, 2007
Role of FoxO1 in FFA-induced oxidative stress in adipocytesAngela R Subauste, Charles F Burant
Molecular Biosystems|January 5, 2013
Network motifs provide signatures that characterize metabolismErin R Shellman, Charles F Burant, Santiago Schnell
The Journal of Nutrition|July 13, 2021
Advantages of Studying the Metabolome in Response to Mixed-Macronutrient Challenges and Suggestions for Future Research DesignsJennifer L LaBarre, Kanakadurga Singer, Charles F Burant
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Diabetes Care|July 25, 2013
Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetesCharles F Burant
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 20, 2003
DGAT: novel therapeutic target for obesity and type 2 diabetes mellitusAngela Subauste, Charles F Burant
Nature Medicine|May 7, 2011
PPAR-γ action: it's all in your headMartin G Myers, Charles F Burant
Trends in Endocrinology and Metabolism: TEM|February 21, 2002
Connecting islet development and developing useful isletsCharles F Burant, Diane M Simeone
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2005
Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporterOrmond A MacDougald, Charles F Burant
Cell Metabolism|September 5, 2007
The rapidly expanding family of adipokinesOrmond A MacDougald, Charles F Burant
Nature Cell Biology|June 2, 2005
Fickle factor foils fat fateOrmond A MacDougald, Charles F Burant
American Journal of Physiology. Endocrinology and Metabolism|March 22, 2007
Role of FoxO1 in FFA-induced oxidative stress in adipocytesAngela R Subauste, Charles F Burant
Molecular Biosystems|January 5, 2013
Network motifs provide signatures that characterize metabolismErin R Shellman, Charles F Burant, Santiago Schnell
The Journal of Nutrition|July 13, 2021
Advantages of Studying the Metabolome in Response to Mixed-Macronutrient Challenges and Suggestions for Future Research DesignsJennifer L LaBarre, Kanakadurga Singer, Charles F Burant
Pageof 15